Sanofi SA (SAN) PT Set at €76.00 by JPMorgan Chase & Co.
Sanofi SA (EPA:SAN) has been assigned a €76.00 ($80.00) target price by research analysts at JPMorgan Chase & Co. in a research report issued to clients and investors on Monday. The firm currently has a “sell” rating on the stock.
Several other brokerages have also recently commented on SAN. Deutsche Bank AG set a €95.00 ($100.00) price target on shares of Sanofi SA and gave the stock a “buy” rating in a research report on Thursday, October 13th. Societe Generale set a €100.00 ($105.26) price target on shares of Sanofi SA and gave the stock a “buy” rating in a research report on Monday, August 1st. Jefferies Group set a €80.00 ($84.21) price target on shares of Sanofi SA and gave the stock a “neutral” rating in a research report on Thursday, August 4th. Sanford C. Bernstein set a €75.00 ($78.95) price target on shares of Sanofi SA and gave the stock a “neutral” rating in a research report on Wednesday, October 19th. Finally, Kepler Capital Markets set a €89.00 ($93.68) price target on shares of Sanofi SA and gave the stock a “buy” rating in a research report on Thursday, August 11th. One analyst has rated the stock with a sell rating, seven have issued a hold rating and seven have given a buy rating to the company. The company has an average rating of “Hold” and an average price target of €84.00 ($88.42).
Shares of Sanofi SA (EPA:SAN) opened at 76.32 on Monday. The firm has a market capitalization of €98.22 billion and a P/E ratio of 23.42. Sanofi SA has a 52-week low of €62.50 and a 52-week high of €84.81. The company’s 50-day moving average price is €25.50 and its 200-day moving average price is €25.74.
COPYRIGHT VIOLATION WARNING: This piece of content was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece of content on another site, it was copied illegally and reposted in violation of U.S. and international copyright and trademark legislation. The correct version of this piece of content can be read at https://www.thecerbatgem.com/2016/11/30/sanofi-sa-san-pt-set-at-76-00-by-jpmorgan-chase-co.html.
About Sanofi SA
Sanofi, formerly Sanofi-Aventis, is a healthcare company engaged in the research, development, manufacture and marketing of therapeutic solutions. The Company operates through three segments: Pharmaceuticals, Human Vaccines (Vaccines) and Animal Health. The Pharmaceuticals segment consists of research, development, production and marketing of medicines, including those originating from Genzyme Corporation.
Receive News & Stock Ratings for Sanofi SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi SA and related stocks with our FREE daily email newsletter.